Navigating 11 Analyst Ratings For 10x Genomics
Navigating 11 Analyst Ratings For 10x Genomics
浏览10x genomics的11个分析师评级
During the last three months, 11 analysts shared their evaluations of 10x Genomics (NASDAQ:TXG), revealing diverse outlooks from bullish to bearish.
在过去的三个月中，11位分析师分享了他们对10x Genomics（纳斯达克股票代码：TXG）的评估，揭示了从看涨到看跌的不同前景。
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
下表概述了他们最近的评级，简要介绍了过去30天中不断变化的情绪，并将其与前几个月进行了比较。
Analysts have recently evaluated 10x Genomics and provided 12-month price targets. The average target is $26.0, accompanied by a high estimate of $46.00 and a low estimate of $16.00. A 35.0% drop is evident in the current average compared to the previous average price target of $40.00.
分析师最近对10x Genomics进行了评估，并提供了12个月的价格目标。平均目标为26.0美元，最高估计值为46.00美元，低估值为16.00美元。与之前的平均目标股价40.00美元相比，当前的平均价格下降了35.0％。
Interpreting Analyst Ratings: A Closer Look
解读分析师评级：仔细观察
The analysis of recent analyst actions sheds light...
对分析师近期行为...
登录免费看全文
登录/注册